GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Neurobiological Technologies NTII · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2010

Revenue

$6.0m

FY2010FY2010

Net income

$4.9m

FY2010FY2010

Free cash flow

$4.8m

FY2010FY2010

Shareholders' equity

$1.5m

FY2010FY2010

Income statement

Fiscal years

FY2010
Revenue$6.0m
Gross profit$6.0m
Operating income$4.5m
Net income$4.9m

Balance sheet

At each fiscal year end

FY2010
Total assets$2.6m
Total liabilities$1.0m
Shareholders' equity$1.5m

Cash flow

Fiscal years

FY2010
Cash from operations$4.8m
Free cash flow$4.8m
Dividends paid−$25.1m

Latest quarters

By quarter end

Dec 2009Sept 2009Jun 2009Mar 2009Dec 2008Sept 2008Jun 2008Mar 2008
Revenue—$6.0m$16.3m$3.0m$3.5m$3.6m$3.5m$3.7m
Gross profit—$6.0m$16.3m$3.0m————
Operating income−$663,000$5.1m$15.3m$318,000————
Net income−$462,000$5.4m$14.2m−$431,000————
Diluted earnings per share-0.020.200.53-0.02-0.29-0.10-0.13-0.19
Cash from operations$2.0m$2.0m−$5.0m−$3.0m————
Total assets$3.2m$29.8m$24.7m$29.3m$32.9m$39.3m$43.2m$47.8m
Cash and short-term investments$3.2m———————
Shareholders' equity$1.3m$28.9m$23.3m$7.8m$8.3m$17.2m$20.3m$23.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-30.1%14.2%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin100.0%100.0%——
Operating margin25.1%-37.3%——
Net margin24.9%-34.5%——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%-0%400%-99%10799519%-84%116%558%-31%-36%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 18 Dec 2012.

FY2010
Paid in the year0.00
  • 7-to-1 reverse split · 17 Sept 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.